BNP/CALL/MERCK & CO./110/0.1/20.12.24 Share Price

Warrant

DE000PE89AE0

Market Closed - Deutsche Boerse AG 20:50:24 04/07/2024 BST
1.76 EUR -2.22% Intraday chart for BNP/CALL/MERCK & CO./110/0.1/20.12.24
Current month-7.37%
1 month-15.38%
Date Price Change
04/07/24 1.76 -2.22%
03/07/24 1.8 -9.55%
02/07/24 1.99 -2.45%
01/07/24 2.04 +7.37%
28/06/24 1.9 -12.84%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE89AE
ISINDE000PE89AE0
Date issued 16/02/2023
Strike 110 $
Maturity 20/12/2024 (169 Days)
Parity 10 : 1
Emission price 1.32
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.58
Lowest since issue 0.52
Delta0.82x
Omega 5.366
Premium2.65x
Gearing6.56x
Moneyness 1.144
Difference Strike -15.85 $
Difference Strike %-14.41%
Spread 0.03
Spread %1.68%
Intrinsic value 1.466

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus